Can spinal anaesthesia be performed now for a caesarean section in a day‑1 dengue patient who is afebrile with a platelet count of 159 ×10⁹/L and no evidence of coagulopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Spinal Anaesthesia for Caesarean Section in Day-1 Dengue Patient

Yes, spinal anaesthesia can be safely performed now for this caesarean section in a day-1 dengue patient who is afebrile with a platelet count of 159 ×10⁹/L, as this platelet level is well above the minimum threshold of 75,000 ×10⁹/L recommended for neuraxial procedures in obstetric patients with normal platelet function. 1

Key Decision Points

Platelet Count Assessment

  • The patient's platelet count of 159 ×10⁹/L exceeds all safety thresholds for neuraxial anaesthesia in obstetric patients 1
  • Guidelines recommend a minimum platelet count of 75,000 ×10⁹/L for neuraxial procedures in obstetric populations, provided platelet function is expected to be normal 1
  • The most recent 2025 ISTH consensus recommends platelet counts ≥75 ×10⁹/L for neuraxial anaesthesia in patients with platelet disorders and mild bleeding history 1

Dengue-Specific Considerations

  • Dengue infection itself is NOT a contraindication to neuraxial anaesthesia 1
  • The patient being afebrile on day 1 and having a platelet count of 159 ×10⁹/L indicates early, non-severe disease 2
  • Routine indications and contraindications for neuraxial anaesthesia apply when managing dengue patients 1

Additional Safety Checks Required Before Proceeding

  • Verify absence of coagulopathy by checking PT/INR and aPTT, as dengue can cause coagulation abnormalities independent of platelet count 2
  • Confirm no clinical bleeding manifestations (petechiae, mucosal bleeding, hematuria) 3, 4
  • Ensure no signs of severe dengue (plasma leakage, severe bleeding, organ impairment) 3

Why Neuraxial Anaesthesia is Preferred

Advantages Over General Anaesthesia

  • Neuraxial anaesthesia should be the preferred technique for caesarean section to avoid risks of difficult intubation, pulmonary aspiration, and inferior postoperative analgesia associated with general anaesthesia in pregnant women 1
  • General anaesthesia carries higher maternal risks in obstetric patients and should be reserved for situations with contraindications to neuraxial techniques 1

Evidence from Viral Infections

  • Studies of obstetric patients with COVID-19 infection demonstrated safe neuraxial anaesthesia use with no contraindications, haemodynamic instability, or neurological complications in patients without thrombocytopenia or sepsis 1
  • This experience with viral infections supports the safety of neuraxial techniques in dengue patients meeting platelet thresholds 1

Critical Monitoring Points

Intraoperative Management

  • Be prepared to manage hypotension with vasopressors, as neuraxial anaesthesia can cause hypotension regardless of dengue status 1
  • Use standard aseptic techniques as for non-dengue patients 1
  • Avoid reducing spinal anaesthetic doses, as conversion to general anaesthesia is the least desirable outcome 1

Laboratory Surveillance

  • Although conventional coagulation tests (PT, aPTT) are typically normal in dengue patients with thrombocytopenia, thromboelastometry studies show hypocoagulability in 71.7% of dengue patients despite normal standard tests 2
  • This discrepancy suggests checking coagulation parameters before proceeding, even with adequate platelet counts 2

Common Pitfalls to Avoid

  • Do not delay necessary caesarean section waiting for higher platelet counts when the current level (159 ×10⁹/L) is already safe 1
  • Do not assume bleeding risk correlates directly with platelet count in dengue, as platelet counts do not correlate well with clinical bleeding 3
  • Do not overlook coagulation abnormalities that may exist despite normal platelet counts in dengue patients 2
  • Bleeding complications in dengue can occur at platelet counts up to 70,000/mm³, but this patient's count of 159,000/mm³ provides substantial safety margin 4

Contraindications That Would Change This Decision

Neuraxial anaesthesia should be deferred or avoided if:

  • Platelet count drops below 75,000 ×10⁹/L 1
  • Evidence of coagulopathy (INR >2.0, aPTT >60 seconds) develops 4
  • Clinical bleeding manifestations appear 3, 4
  • Signs of severe dengue with plasma leakage or organ dysfunction emerge 3
  • Sepsis or haemodynamic instability develops 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Thrombocytopenia in dengue fever.

Current hematology reports, 2005

Research

Prevalence, patterns, and factors associated with bleeding tendencies in dengue.

Journal of infection in developing countries, 2015

Related Questions

What is the mechanism of deranged activated partial thromboplastin time (aPTT) in dengue fever?
What is the recommended approach for monitoring platelets in patients with dengue fever and thrombocytopenia?
What is the treatment for an 8-year-old with dengue (Dengue Virus Infection) and thrombocytopenia (low platelet count)?
What is the management for a patient with dengue fever without warning signs but with thrombocytopenia (platelet count of 63)?
Should we continue atorvastatin (lipid-lowering medication) in a patient with dengue and thrombocytopenia?
What is the recommended diet for a medically stable adult with type 2 diabetes mellitus to achieve optimal glycaemic control, maintain a healthy weight, and reduce cardiovascular risk?
In a young adult with major depressive disorder, ADHD currently on a stimulant, recent inappropriate cariprazine exposure, active substance use, and severe insomnia, should ADHD be treated concurrently rather than waiting for mood stabilization?
What are the causes of thrombocytopenia in cardiogenic shock?
In a primary care patient with a previously pea-sized epidermoid cyst on the neck that is now painful, erythematous, and enlarging, what is the best management for the infected cyst?
For a patient with in‑stent restenosis, which treatment is preferred—second‑generation drug‑eluting stent (DES), drug‑eluting balloon (DEB), or plain old balloon angioplasty (POBA)?
Why does a patient feel physically and psychologically better three days after starting sildenafil for erectile dysfunction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.